复肝康冲剂治疗乙型肝炎疗效观察

Investigation on Curative Effect of Fugankang GrannulesRadix Bupleuri,Radix Salviac Miltiorrhizae ,etc.)for Hepatitis B

用复肝康冲剂治疗乙型肝炎３４例，剂量１０ｇ，ｐｏ，ｔｉｄ，连用３月，并与小剂量人白细胞α－干扰素联合较大剂量聚肌胞治疗３２例作比较。结果二组有效率分别为８２．４％和７８．１％，无显著性差异（Ｐ＞０．０５）；复肝康冲剂对缓解症状，改善体征的疗效更为显著；对肝功能改善，乙型肝炎病毒标志阴转，二组疗效相当。

Fugankang Granules were orally given to 34 patients with hepatitis B in a dosage of 10g,3 times a day(comtinuous treatment for 3 months).Its effect was compared with that of control group(3 2 cases) treated by small dose of human white-cell α-interferon and more dose of polyinosinic-polycytidylic acid combined.As a result,the effective rates of two groups are 4% and 78.1%, respectively,without a significant difference(p>0.5).Fugankang Granules have more obviously curative effects in the remission of symptoms and improvement of signs. But the two groups showed equivalently curative effects in improvement of liver function and virus marker of hepatitis B turnning negative.